← All stocks

SELLAS Life Sciences Group, Inc.

SLS No buying or selling
CIK 0001390478 #1826 in the set updated 20 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

8 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Stergiou Angelos M.
President and CEO
1,759,183
$2.80M
+330.5%
CICIC DRAGAN
SVP, Chief Development Officer
557,805
$886.91K
+311.5%
Burns John Thomas
CFO
554,327
$881.38K
+340.7%
Kalin Katherine Bach
Director
154,400
$245.50K
+1,716%
Wasman Jane
Director
92,900
$147.71K
+793.3%
VAN NOSTRAND ROBERT L
Director
82,900
$131.81K
+697.1%
SCHEINBERG DAVID A
Director
73,082
$116.20K
+590.6%
Varian John
Director
72,900
$115.91K
+601.0%

No percentages here. This company's share count has moved by a factor of 2.9 over the window, from 70,381,979 to 201,945,709 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 15 Nov 2016